Arbutus Biopharma
ABUS
#7051
Rank
โ‚น57.10 B
Marketcap
โ‚น372.49
Share price
-1.23%
Change (1 day)
-3.53%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2026 (TTM): โ‚น14.35 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are โ‚น0.18 Billion. In 2025 the company made an earning of -โ‚น3.11 Billion, an increase over its 2024 earnings that were of -โ‚น6.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น14.35 B-562.3%
2025 -โ‚น3.11 Billion-52.09%
2024 -โ‚น6.48 Billion-4.02%
2023 -โ‚น6.76 Billion12.05%
2022 -โ‚น6.03 Billion-14.74%
2021 -โ‚น7.07 Billion19.61%
2020 -โ‚น5.91 Billion-61.69%
2019 -โ‚น15.42 Billion171.23%
2018 -โ‚น5.69 Billion-43.58%
2017 -โ‚น10.08 Billion-77.77%
2016 -โ‚น45.33 Billion532.77%
2015 -โ‚น7.17 Billion99.05%
2014 -โ‚น3.6 Billion175.82%
2013 -โ‚น1.31 Billion-143.7%
2012 โ‚น2.98 B-399.11%
2011 -โ‚น1 Billion-39.03%
2010 -โ‚น1.64 Billion100.55%
2009 -โ‚น0.82 Billion-28.56%
2008 -โ‚น1.15 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-โ‚น0.21 Billion-101.41% Bahamas
NRC Health
NRC
โ‚น1.37 B-90.34%๐Ÿ‡บ๐Ÿ‡ธ USA